多纳芬尼与辛蒂利马布结合治疗晚期肝细胞癌:单臂II期试验

Xiaoyang Hong1,2, Yongjian Guo1, Wenbo Shi1,3

  • 1Department of Minimally Invasive Interventional Radiology, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

BMC cancer
|February 5, 2025
PubMed
概括

多纳费尼布与辛蒂利马布 (Don-Sin) 结合,对晚期肝细胞癌 (HCC) 显示出有前途的抗瘤作用. 这种组合疗法显示了6.2个月的中位数无进展生存期,具有可接受的安全性.